Mepolizumab and the treatment of chronic rhinosinusitis
Dr. Joseph Han discusses the results of the phase III SYNAPSE trial, evaluating the efficacy and safety of mepolizumab in patients with chronic rhinosinusitis. Read the full article: https://www.thel...
16 Apr 20217min
Inhaled budesonide in the treatment of early COVID-19
Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19. Read the full article: https://www.thelancet.com/journals/lanres/article...
15 Apr 202110min
Tocilizumab and COVID-19
Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome. Read the full a...
5 Mar 20215min
Interferon treatment and COVID-19
Jordan Feld discusses the use of peginterferon-lambda in the treatment of ambulatory COVID-19 patients. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30566...
6 Feb 20216min
Evaluating deterioration in patients with acute COVID-19
Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19. Read the full article: https://www.thelancet.com/journals/lanres/article/PIIS...
12 Jan 20218min
Treatment options in patients with systemic sclerosis-associated interstitial lung disease
Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate....
5 Jan 202115min
COVID-19 and severe influenza
Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ. Continue this conversation on social! Follow us today at... https://thelancet.bsk...
18 Des 20208min
The second wave and homeless populations
Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19. Continue this conversation on social! Follow us ...
11 Nov 20207min
